课题基金 / 基金详情

项目摘要

项目成果

VSEVOLOD V. GUREVICH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The decrease of cell responsiveness to a persistent stimulus, usually termed desensitization, is a widespread biological phenomenon. Visual amplification cascade (and the signaling by other G protein-coupled receptors) is attenuated by a two-step mechanism: phosphorylation of light-activated rhodopsin (Rh*) by rhodopsin kinase followed by arrestin binding to light-activated phosphorylated rhodopsin (P-Rh*). Arrestin binding terminates transducin-mediated signaling, playing an important role in the recovery of photoreceptor cells. The main objective of this proposal is to elucidate how the fine molecular mechanisms of visual arrestin function translate into its timely binding to rhodopsin, subsequent dissociation from phosphoopsin, its translocation into rod outer segment in the light and its movement to the inner segment in the dark. Using site-directed mutagenesis, direct binding assay, spin labeling of arrestin and rhodopsin followed by EPR spectroscopy, and X-ray crystallography we will identify arrestin and rhodopsin residues participating in their interaction. We will elucidate the number of rhodopsin-attached phosphates necessary for tight arrestin binding and the role of arrestin and rhodopsin dimerization in their interaction. We will use custom-designed arrestin mutants expressed in transgenic mice to study the kinetics of signal shut-off and recovery in rods, the physiological role of arrestin self-association and function of its light-dependent translocation. Several congenital disorders are associated with excessive rhodopsin signaling. We have created phosphorylation-independent "super-arrestins" binding with high affinity to P-Rh* and Rh*, that appear to be logical tools for gene therapy of these disorders. The feasibility of using "super-arrestins" as tools for correcting response kinetics and preventing retinal degeneration in mouse models with the loss of rhodopsin phosphorylation sites or rhodopsin kinase will be also tested.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Engineering of Designer Arrestins to Regulate Cell Signaling
  • 批准号:
    9275751
  • 项目类别:
  • 资助金额:
    $34.14万
  • 财政年份:
    2017
  • 负责人:
    VSEVOLOD V. GUREVICH
  • 依托单位:
Targeted Engineering of Designer Arrestins to Regulate Cell Signaling
  • 批准号:
    9914303
  • 项目类别:
  • 资助金额:
    $56.5万
  • 财政年份:
    2017
  • 负责人:
    VSEVOLOD V. GUREVICH
  • 依托单位:
Regulation of GPCR signaling with receptor-specific arrestins
  • 批准号:
    9189631
  • 项目类别:
  • 资助金额:
    $37.17万
  • 财政年份:
    2015
  • 负责人:
    VSEVOLOD V. GUREVICH
  • 依托单位:
Regulation of GPCR signaling with receptor-specific arrestins
  • 批准号:
    8985683
  • 项目类别:
  • 资助金额:
    $37.17万
  • 财政年份:
    2015
  • 负责人:
    VSEVOLOD V. GUREVICH
  • 依托单位:
国内基金
海外基金
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
  • 批准号:
    2026JJ81069
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    朱萱
  • 依托单位:
电针刺激ST36通过DRD1/β-arrestin1信 号通路抑制炎症性骨丢失的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘冠峤
  • 依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    时佳琪
  • 依托单位:
电针激活β-arrestin 1/IFN通路促进"冷-热"免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究